Satellite Bio Funding: $110M Raised, Series A (2022)
Satellite Bio is based in Cambridge, Massachusetts. It has raised $110M in total funding. Latest round: Series A.
Satellite Bio funding overview
Satellite Bio is based in Cambridge, Massachusetts. Satellite Bio has raised $110M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in April 2022. The round record for Satellite Bio runs through 2022; nothing later has been disclosed. Investors on record include aMoon Fund, Lightspeed Venture Partners, Polaris Partners, Section 32, Catalio Capital Management, Waterman Ventures. 6 distinct backers are named across the disclosed rounds.
Satellite Bio has raised $110M in total disclosed funding across the rounds on record.
Who has invested in Satellite Bio?
aMoon Fund, Lightspeed Venture Partners, Polaris Partners, Section 32, Catalio Capital Management, Waterman Ventures are named among the investors backing Satellite Bio.
What was the latest Satellite Bio funding round?
The most recent disclosed round is a Series A, announced in April 2022.
Where is Satellite Bio based?
Satellite Bio is based in Cambridge, Massachusetts.
When did Satellite Bio last raise?
The last disclosed Satellite Bio round closed in April 2022 at Series A.
Totals shown for Satellite Bio aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
